[Disoprivan for the induction and maintenance of short anesthesia].
Disoprivan (Propofol) was used for induction and maintenance of anaesthesia for short surgical procedures in non-premedicated and premedicated (0.5 mg atropine, 3 mg midazolam) patients. A dose of 130-150 mg Disoprivan was adequate for induction, and a dose of 72 and of 62 micrograms/kg body weight/min anaesthesia respectively, for maintenance, together with N2O/O2 2:1. The anaesthesia was characterized by an apnoea of 40-60 s duration, a decrease in arterial blood pressure of 20%, a slowing of heart rate in non-premedicated patients by 12 beats/min and a rapid and pleasant recovery with lack of emetic sequelae. Disoprivan is considered useful for this type of anaesthesia.
D000328:Adult; D000777:Anesthetics; D005260:Female; D005831:Genital Diseases, Female / Q000601:surgery; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009609:Nitrous Oxide; D010636:Phenols / Q000009:adverse effects; D011229:Preanesthetic Medication; D015742:Propofol
D000777:Anesthetics; D010636:Phenols; D009609:Nitrous Oxide; D015742:Propofol
Disoprivan zur Einleitung und Unterhaltung von Kurznarkosen.